Answers are grounded in this paper and cite their sources.
The hepatitis E virus (HEV) can cause acute viral hepatitis with or without neurological manifestations, and occasionally progresses to chronic infection in immunocompromised individuals. The management of chronic HEV infection in cancer patients may be challenging due to the complex immunological constellation. Furthermore, the diagnostic workflow and the impact on quality of life of neurological HEV manifestations in immunocompromised patients have not been sufficiently delineated previously.
No takes yet. Share an insight, caveat, or question.
Ritter et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: